Daniel Zips Selected Research

Gallium-68

1/2022

Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Zips Research Topics

Disease

91	Neoplasms (Cancer) 06/2024 - 01/2002
43	Squamous Cell Carcinoma of Head and Neck 12/2023 - 01/2010
38	Hypoxia (Hypoxemia) 01/2023 - 06/2004
34	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 12/2007
26	Head and Neck Neoplasms (Head and Neck Cancer) 09/2023 - 10/2012
20	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 02/2002
15	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2014
13	Hyperthermia 01/2023 - 07/2015
13	Rectal Neoplasms (Rectal Cancer) 01/2023 - 01/2016
12	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 10/2005
10	Sarcoma (Soft Tissue Sarcoma) 07/2023 - 01/2018
6	Carcinoma (Carcinomatosis) 09/2022 - 12/2014
5	Brain Neoplasms (Brain Tumor) 12/2023 - 03/2016
4	Necrosis 11/2023 - 06/2005
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
4	Lymphatic Metastasis 02/2019 - 05/2011
4	Body Weight (Weight, Body) 12/2014 - 03/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 09/2008
3	Infections 12/2022 - 12/2018
3	Meningioma (Meningiomas) 06/2021 - 12/2019
3	Melanoma (Melanoma, Malignant) 01/2019 - 10/2014
3	Lung Neoplasms (Lung Cancer) 02/2018 - 08/2004
2	Ventricular Tachycardia 12/2023 - 01/2023
2	Heart Failure 12/2023 - 01/2023
2	Wounds and Injuries (Trauma) 12/2022 - 09/2009
2	Triple Negative Breast Neoplasms 08/2022 - 09/2020
2	Disease Progression 01/2022 - 03/2021
2	Fatigue 09/2021 - 04/2021
2	Inflammation (Inflammations) 01/2021 - 12/2018
2	Glioma (Gliomas) 01/2020 - 09/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 03/2019 - 10/2013
2	Deglutition Disorders (Dysphagia) 10/2018 - 01/2015
2	Rhabdomyosarcoma 01/2017 - 11/2016
1	Alzheimer Disease (Alzheimer's Disease) 11/2023
1	Amyloid Plaque 11/2023
1	Neurofibrosarcoma (MPNST) 11/2023
1	Edema (Dropsy) 11/2023

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 06/2024 - 11/2006
21	fluoromisonidazoleIBA 01/2023 - 10/2012
14	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 12/2014
10	pimonidazoleIBA 11/2012 - 08/2005
9	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2016
8	Messenger RNA (mRNA)IBA 11/2023 - 09/2015
7	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 12/2014
5	AndrogensIBA 10/2023 - 01/2018
5	Oxygen (Dioxygen)IBA 01/2023 - 10/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2006
4	Phosphotransferases (Kinase)IBA 08/2017 - 03/2005
4	Lactic Acid (Lactate)FDA LinkGeneric 07/2010 - 11/2006
3	Protons (Proton)IBA 06/2023 - 11/2006
3	AntigensIBA 01/2023 - 11/2012
3	Prostate-Specific Antigen (Semenogelase)IBA 10/2022 - 12/2020
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 11/2006
3	Fura-2 (Fura 2)IBA 01/2020 - 03/2016
3	CytokinesIBA 04/2018 - 01/2017
3	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 11/2012 - 09/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012 - 03/2005
3	vatalanib (PTK787)IBA 06/2005 - 09/2003
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2005 - 09/2003
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2023 - 07/2023
2	A-Form DNA (A-DNA)IBA 01/2023 - 11/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 12/2018
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 07/2022 - 01/2019
2	Hormones (Hormone)IBA 01/2022 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 01/2021
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2017
2	Complement System Proteins (Complement)IBA 09/2019 - 12/2018
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
2	Radiation-Sensitizing AgentsIBA 09/2015 - 05/2007
2	NitroimidazolesIBA 01/2015 - 06/2004
2	AfatinibIBA 12/2014 - 05/2007
2	Cetuximab (Erbitux)FDA Link 02/2014 - 01/2013
2	Plasminogen Activator Inhibitor 1IBA 11/2012 - 03/2008
2	Pyruvic Acid (Pyruvate)IBA 01/2010 - 11/2006
2	Tyrosine Kinase InhibitorsIBA 05/2007 - 03/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2007 - 06/2005
2	Tyrosine (L-Tyrosine)FDA Link 06/2005 - 03/2005

Therapy/Procedure

101	Radiotherapy 12/2023 - 06/2004
50	Chemoradiotherapy 09/2023 - 10/2012
43	Therapeutics 06/2024 - 07/2010
16	Drug Therapy (Chemotherapy) 01/2023 - 07/2010
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2021 - 01/2013
6	Immunotherapy 01/2019 - 01/2017
4	Particle Accelerators 01/2024 - 01/2021
4	Neoadjuvant Therapy 12/2022 - 05/2011
4	Image-Guided Radiotherapy 04/2022 - 07/2015
3	Re-Irradiation 03/2024 - 01/2023
3	Prostatectomy (Retropubic Prostatectomy) 10/2023 - 01/2018
3	Adjuvant Radiotherapy 12/2022 - 08/2017
3	Proton Therapy 12/2022 - 01/2015
2	Precision Medicine 06/2024 - 01/2023
2	Heart-Assist Devices 12/2023 - 01/2023
2	Combined Modality Therapy 12/2022 - 11/2018
2	Castration 04/2022 - 01/2022
2	Gastrostomy 12/2018 - 10/2018
2	Radioimmunotherapy 04/2018 - 02/2014
2	Brachytherapy 11/2016 - 12/2007
1	Catheters 12/2023
1	Radiofrequency Ablation 12/2023